Teva Pharmaceutical Industries Limited growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +4.4%
EBITDA: +27.3%
EBIT: +427.4%
EPS: +221.2%
Free cash flow: +53.2%
Operating cash flow: +35.4%

Forward estimates

Revenue: -3.5%
EBITDA: -21.8%
EPS: +106.2%

Three-year CAGR

Revenue: +5.0%
EBITDA: +42.0%
EBIT: +123.2%
Net income: +186.0%
EPS: +184.8%
Free cash flow: +3.3%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.